SB-Losak Plus 100 mg+25 mg (Tablet)
Unit Price: ৳ 12.00 (30's pack: ৳ 360.00)
Medicine Details
Category | Details |
---|---|
Generic | Losartan potassium hydrochlorothiazide |
Company | Sunman birdem pharma ltd |
Also available as |
Indications
- Treatment of hypertension
- Risk reduction of stroke in hypertensive patients with left ventricular hypertrophy
Pharmacology
- Losartan blocks vasoconstrictor and aldosterone-secreting effects of angiotensin II
- Hydrochlorothiazide affects renal tubular mechanisms of electrolyte reabsorption
Dosage
- Usual starting dose of 50/12.5 is one tablet once daily
- Maximum dose is 100/25 once daily for hypertension
- Initial treatment for severe hypertension is one tablet of 50/12.5 once daily
- Antihypertensive effect is attained within three weeks after initiation of therapy
Administration
May be administered with other antihypertensive agents. Can be taken with or without food.
Interaction
- No significant drug-drug interactions with Losartan
- Interaction with thiazide diuretics may potentiate orthostatic hypotension
- Dosage adjustment of antidiabetic drugs may be required when administered concurrently with Hydrochlorothiazide
Contraindications
- Contraindicated in patients hypersensitive to any component
- Contraindicated in patients with anuria or hypersensitivity to sulfonamide-derived drugs
Side Effects
- Symptomatic hypotension including dizziness may occur
- Hyperkalaemia and angioedema may occur
- Other side effects include vertigo, gastrointestinal disturbances, angina, palpitation, oedema, dyspnoea, headache, etc.
Pregnancy & Lactation
- Avoid in pregnancy unless essential
- Not recommended in breastfeeding
- May adversely affect fetal and neonatal blood pressure control and renal function
Precautions & Warnings
- Periodic determination of serum electrolytes should be performed
- Hypokalemia may rarely develop, especially with brisk diuresis
- Impaired renal function and symptomatic hypotension should be monitored
Use in Special Populations
- Use with caution in patients with renal impairment
- Not recommended for titration in patients with hepatic impairment
- Safety and effectiveness in pediatric patients not established
Overdose Effects
- Manifestations of overdosage include hypotension, tachycardia, and electrolyte depletion
- Supportive treatment should be instituted for symptomatic hypotension
Therapeutic Class
Combined antihypertensive preparations
Storage Conditions
Do not store above 30°C. Keep out of the reach of children
Related Brands
- Losamax-H 50 mg+12.5 mg (Tablet) - veritas-pharmaceuticals-ltd
- Tanpot Plus 50 mg+12.5 mg (Tablet) - albion-laboratories-limited
- Losapot Plus 50 mg+12.5 mg (Tablet) - somatec-pharmaceuticals-ltd
- Losartium-H 50 mg+12.5 mg (Tablet) - rangs-pharmaceuticals-ltd
- Losa Plus 50 mg+12.5 mg (Tablet) - alco-pharma-ltd